Recombinant Human EGF (Epidermal Growth Factor) is a peptide that binds to the membrane receptor called EGF receptor in humans to promote cell proliferation and cell differentiation. EGF acts by initiating number of cell signaling cascade pathways such as activating genes for cell proliferation, cell differentiation, protein synthesis, and improving efficiency of DNA topoisomerase. Traditionally, EGF was isolated from animal urine but with recent advances in biotechnology, the production and extraction of recombinant EGF have become possible in a lab setting. Recombinant EGF can be produced using various biological systems such as Escherichia coli, tobacco, rice, yeast, and others. EGF can be used for several applications in the field of medicine, research, cell culture, cosmetology, and others. EGF exhibits medically important properties such as initiation of growth and division in cells that can be exploited for clinical application of wound healing as well as for the treatment of ulcers. For instance, according to an article published by the American Institute of Physics in June 2020, high levels of recombinant human EGF (rhEGF) were obtained by co-expression of human EGF (hEGF) in Escherichia coli with Bacillus cereus phospholipase C. This rhEGF can then be used for the treatment of diabetic foot ulcers along with other wound treatments.
Market Dynamics
Market players are conducting clinical trials for analyzing the potential uses of human EGF in healthcare sector, this could contribute to the growth of the market over the forecast period. For instance, a clinical trial study was initiated in July 2017 by Hallym University Kangnam Sacred Heart Hospital, Korea, for determining the effectiveness of recombinant human EGF ointment in healing lesions caused by laser treatment for solar lentigines. The study was completed in December 2018 and the results were published by PubMed in February 2021. Results showed that the use of recombinant human EGF ointment was safe and efficient for healing lesions.
Market players are involved in acquisitions of other companies in order to enhance distribution. For instance, in 2018, FUJIFILM, a Japanese multinational conglomerate, acquired Irvine Scientific Sales Company, Inc., a cell media specialist, to expand its range of cell culture media products including recombinant human EGF. This is expected to drive the growth of the recombinant human EGF market.
Key features of the study
• This report provides an in-depth analysis of global recombinant human EGF market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2026-2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global recombinant human EGF market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include Thermo Fisher Scientific, FUJIFILM Irvine Scientific, Inc., ScienCell Research Laboratories, R&D Systems, Abcam PLC, Cell Sciences, Inc., Eurofins DiscoverX, PeproTech, Inc., RayBiotech, Inc., Prospec-Tany TechnoGene Ltd., Miltenyi Biotec, Tonbo Biosciences, BioLegend, Inc., EnQuire BioReagents, STEMCELL Technologies Inc., Cell Guidance Systems Ltd., Creative BioMart, Sino Biological Inc., and BioVision, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global recombinant human EGF market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision making through various strategy matrices used in analyzing the recombinant human EGF market
Market Segmentation
• By Product Type (Revenue, USD Bn, 2021-2033)
o Heparin Binding-EGF
o Transforming Growth Factor-α
o Epigen
o Neuregulins
o Amphiregulin
o Betacellulin
o Others
• By Purity (Revenue, USD Bn, 2021-2033)
o 98% SDS-PAGE
o 95%-98% SDS-PAGE
o <95% SDS-PAGE
• By Carrier Type (Revenue, USD Bn, 2021-2033)
o Carrier Protein
o Carrier Free
• By Formulation (Revenue, USD Bn, 2021-2033)
o Lyophilized Powder
o Liquid
o Others
• By Application (Revenue, USD Bn, 2021-2033)
o Wound Healing
o Gastrointestinal Ulceration
o Brain Tumor Therapy
o Others
• By Region (Revenue, USD Bn, 2021-2033)
o North America
U.S.
Canada
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
South Africa
Central Africa
North Africa
• Key Players
o Thermo Fisher Scientific
o FUJIFILM Irvine Scientific, Inc.
o ScienCell Research Laboratories
o R&D Systems
o Abcam PLC
o Cell Sciences, Inc.
o Eurofins DiscoverX
o PeproTech, Inc.
o RayBiotech, Inc.
o Prospec-Tany TechnoGene Ltd.
o Miltenyi Biotec
o Tonbo Biosciences
o BioLegend, Inc.
o EnQuire BioReagents
o STEMCELL Technologies Inc.
o Cell Guidance Systems Ltd.
o Creative BioMart
o Sino Biological Inc.
o BioVision, Inc.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Product Type
Market Snapshot, By Purity
Market Snapshot, By Carrier Type
Market Snapshot, By Formulation
Market Snapshot, By Application
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Product Approval
o Collaboration/Merge/Acquisition
o Regulatory Landscape
o PEST Analysis
o Porter’s Five Forces Analysis
o Epidemiology
o Robust Pipeline Analysis
4. Recombinant Human (EGF) Market, By Product Type, 2021 – 2033, (USD Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022– 2033
Segment Trends
o Heparin Binding-EGF
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Transforming Growth Factor-α
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Epigen
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Neuregulins
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Amphiregulin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Betacellulin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
5. Recombinant Human (EGF) Market, By Purity, 2021 – 2033, (USD Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o 98% SDS-PAGE
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o 95%-98% SDS-PAGE
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o <95% SDS-PAGE
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
6. Recombinant Human (EGF) Market, By Carrier Type, 2021 – 2033, (USD Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Carrier Protein
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Carrier Free
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
7. Recombinant Human (EGF) Market, By Formulation, 2021 – 2033, (USD Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Lyophilized Powder
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Liquid
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
8. Recombinant Human (EGF) Market, By Application, 2021 – 2033, (USD Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Wound Healing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Gastrointestinal Ulceration
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Brain Tumor Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
9. Recombinant Human (EGF) Market, By Region, 2021 – 2033, (USD Billion)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022–2033
Regional Trends
o North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Purity, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Carrier Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Purity, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Carrier Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Purity, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Carrier Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Purity, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Carrier Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Purity, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Carrier Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
o GCC
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Purity, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Carrier Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Billion)
o North Africa
o Central Africa
o South Africa
10. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
o Company Profile
Thermo Fisher Scientific
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
FUJIFILM Irvine Scientific, Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
ScienCell Research Laboratories
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
R&D Systems
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Abcam PLC
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Cell Sciences, Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Eurofins DiscoverX
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
PeproTech, Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
RayBiotech, Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Prospec-Tany TechnoGene Ltd.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Miltenyi Biotec
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Tonbo Biosciences
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
BioLegend, Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
EnQuire BioReagents
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
STEMCELL Technologies Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Cell Guidance Systems Ltd.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Creative BioMart
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Sino Biological Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
BioVision, Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
o Analyst Views
11. Section
o References
o Research Methodology
o About Us
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們